Compare Revolution Medicines Inc. Common Stock (RVMD) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revolution Medicines Inc. Common Stock vs Veritone Inc — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B), while Veritone Inc trades at $0.56 (market cap $59.46M). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 678.1× Veritone Inc's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Veritone Inc for 12 Days on average.
| RVMD | VERI | |
|---|---|---|
Market Cap | $40.32B | $59.46M |
Volume | 4,855,734 | 15,523,164 |
Sector | Health | Technology |
52-Week High | $221.15 | $8.39 |
52-Week Low | $47.50 | $0.59 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $37.02B | $94.86M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Veritone (VERI) trades at $0.5647, down 18.31% over 24 hours, reflecting significant bearish pressure. The stock shows mixed signals with a bearish technical outlook but bullish oscillators. Fundamentally, the company reported a net loss of $111.73M in 2025 with a negative net income margin of -117.54%, though revenue remains near $92M. Recent developments include a $15M equity offering and partnerships with ATP Media and ZeroEyes, indicating ongoing business development efforts amidst financial challenges.
The outlook for VERI is highly speculative, with a consensus analyst price target of $3.75 suggesting substantial upside potential from current levels. However, persistent losses, negative cash flow from operations, and ongoing securities litigation pose significant risks. Investment appeal hinges on the company's ability to achieve profitability and monetize its AI solutions, making it suitable only for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
